WAYNE MARTINSEN: Open Payments
NPI 1851352504 · MINOT, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$330 in 16 payments from 8 companies in 2025. Trend: 2023 $159 · 2024 $226 · 2025 $330
Food & beverage: $294Education: $36
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $86 |
| Axsome Therapeutics, Inc. | 3 | $64 |
| Alkermes, Inc. | 3 | $60 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: CAPLYTA, Auvelity, ARISTADA, COBENFY, Jornay PM, AUSTEDO XR, INGREZZA, TRINTELLIX.
Industry payments across ND — which companies pay providers there.
